As described in earlier chapters, mounting evidence suggests that Chlamydia pneumoniae may have a role in the development and/or progression of atherosclerosis and coronary heart disease
2007
Scholarcy highlights
- As described in earlier chapters, mounting evidence suggests that Chlamydia pneumoniae may have a role in the development and/or progression of atherosclerosis and coronary heart disease
- A further important line of evidence has been the results of preliminary anti-chlamydial antibiotic intervention studies in CHD
- This chapter focuses on the potential role of such antimicrobial therapy in the secondary prevention of CHD
- The findings of preliminary pilot studies are reviewed, as are the aims and controversies surrounding subsequent large-scale, prospective intervention trials in progress
Need more features? Save interactive summary cards to your Scholarcy Library.